Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease    2018, Vol. 9 Issue (1) : 119-132     DOI: 10.14336/AD.2017.0202
Review |
Role of Dietary Protein and Muscular Fitness on Longevity and Aging
Strasser Barbara1, Volaklis Konstantinos2, Fuchs Dietmar3, Burtscher Martin4
1Division of Medical Biochemistry, Biocenter, Medical University Innsbruck, Austria
2Department of Prevention and Sports Medicine, TUM, Munich, Germany
3Division of Biological Chemistry, Biocenter, Medical University Innsbruck, Austria
4Department of Sport Science, Medical Section, University Innsbruck, Austria
Download: PDF(936 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    

Muscle atrophy is an unfortunate effect of aging and many diseases and can compromise physical function and impair vital metabolic processes. Low levels of muscular fitness together with insufficient dietary intake are major risk factors for illness and mortality from all causes. Ultimately, muscle wasting contributes significantly to weakness, disability, increased hospitalization, immobility, and loss of independence. However, the extent of muscle wasting differs greatly between individuals due to differences in the aging process per se as well as physical activity levels. Interventions for sarcopenia include exercise and nutrition because both have a positive impact on protein anabolism but also enhance other aspects that contribute to well-being in sarcopenic older adults, such as physical function, quality of life, and anti-inflammatory state. The process of aging is accompanied by chronic immune activation, and sarcopenia may represent a consequence of a counter-regulatory strategy of the immune system. Thereby, the kynurenine pathway is induced, and elevation in the ratio of kynurenine to tryptophan concentrations, which estimates the tryptophan breakdown rate, is often linked with inflammatory conditions and neuropsychiatric symptoms. A combined exercise program consisting of both resistance-type and endurance-type exercise may best help to ameliorate the loss of skeletal muscle mass and function, to prevent muscle aging comorbidities, and to improve physical performance and quality of life. In addition, the use of dietary protein supplementation can further augment protein anabolism but can also contribute to a more active lifestyle, thereby supporting well-being and active aging in the older population.

Keywords Aging      muscle      physical fitness      protein      kynurenine pathway      longevity     
About author:

These authors equally contributed to this work.

Issue Date: 01 February 2018
E-mail this article
E-mail Alert
Articles by authors
Strasser Barbara
Volaklis Konstantinos
Fuchs Dietmar
Burtscher Martin
Cite this article:   
Strasser Barbara,Volaklis Konstantinos,Fuchs Dietmar, et al. Role of Dietary Protein and Muscular Fitness on Longevity and Aging[J]. Aging and disease, 2018, 9(1): 119-132.
URL:     OR
Figure 1.  Age-related decline of endurance and strength performance in trained versus untrained subjects

Age-related decline in the anaerobic threshold (VO2AT) in Master’s mountain runners and sedentary subjects (A) and peak power in Master’s weight lifters and sedentary control subjects (B); (modified from ref. 58, 59).

Figure 2.  The induction of indoleamine 2,3-dioxygenase 1 (IDO1) by aging

The process of aging involves pro-inflammatory pathways which include activation of the T-cell-macrophage axis in the framework of the cell-mediated (Th1-type) immune response in which the formation of Th1-type cytokine interferon-γ (IFN-γ) is of utmost relevance. IFN-γ stimulates a broad spectrum of biochemical pathways that are directed to stop unwanted growth of pathogens or malignant cells. Among them, the conversion of essential amino acid tryptophan to kynurenine is a key element, which on the one hand is involved in a feedback inhibition of T-cell activation via regulatory T-cells and thus immunosuppressive. On the other hand, the catabolites generated by this strategy can impact on the central nervous system when neuroactive compounds accumulate and pro-inflammatory cascades including the formation of reactive oxygen species (ROS) interfere with neuroendocrine signaling, which controls mood and behavior.

Figure 3.  Tryptophan breakdown limits the availability of tryptophan for serotonin synthesis and increases the downstream production of neuroactive metabolites

Enhanced tryptophan breakdown by the enzymes tryptophan 2,3-dioxygenase (tryptophan pyrrolase, TDO) and/or indoleamine 2,3-dioxygenase-1 (IDO-1) can affect several body compartments including the brain. Thereby, various intermediate catabolites such as kynurenic acid, picolinic acid, and quinolinic acid are formed on the route to nicotinamide adenine dinucleotides. Tryptophan shortage during/after the pro-inflammatory response may reduce the availability of the essential amino acid for the biosynthesis of muscle proteins and can thus contribute to sarcopenia development with older age. For the transport of tryptophan and kynurenine into the brain to cross the blood-brain barrier (BBB), the leucine-preferring L1 system is utilized in competition with the so-called large neutral amino acids (LNAA). Once arrived in the brain, astrocytes are able to convert kynurenine to neuroprotective kynurenic acid, whereas glial cells primarily produce its neurotoxic counterpart quinolinic acid. Alternatively, tryptophan is converted by the tryptophan 5-monooxygenase to 5-hydroxytryptophan, which decarboxylates to the product serotonin (5-hydroxytryptamin), an important neurotransmitter and precursor of the sleep hormone melatonin. If brain tryptophan is low, serotonin also decreases and can disturb memory and cognition as well as sleep and mood, which finally increase the risk of development of dementia and depression.

[1] Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE (2002). Exercise capacity and mortality among men referred for exercise testing. N Engl J Med, 346: 793-801.
[2] Sui X, LaMonte MJ, Blair SN (2007). Cardiorespiratory fitness and risk of nonfatal cardiovascular disease in women and men with hypertension. Am J Hypertens, 20: 608-15.
[3] Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al. (2009). Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA, 301: 2024-35.
[4] Hairi NN, Cumming RG, Naganathan V, Handelsman DJ, Le Couteur DG, Creasey H, et al. (2010). Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: the Concord Health and Ageing in Men Project. J Am Geriatr Soc, 58: 2055-62.
[5] Hirsch CH, Buzková P, Robbins JA, Patel KV, Newman AB (2012). Predicting late-life disability and death by the rate of decline in physical performance measures. Age Ageing, 41: 155-61.
[6] Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb JD, et al. (1999). Midlife hand grip strength as a predictor of old age disability. JAMA, 281: 558-60.
[7] Artero EG, Lee DC, Ruiz JR, Sui X, Ortega FB, Church TS, et al. (2011). A prospective study of muscular strength and all-cause mortality in men with hypertension. J Am Coll Cardiol, 57: 1831-37.
[8] Ruiz JR, Sui X, Lobelo F, Morrow JR, Jackson W, Sjoestroem M, et al. (2008). Association between muscular strength and mortality in men: prospective cohort study. BMJ, 337: a439.
[9] Ruiz JR, Sui X, Lobelo F, Lee DC, Morrow JR Jr, Jackson AW, et al. (2009). Muscular strength and adiposity as predictors of adulthood cancer mortality in men. Cancer Epidemiol Biomarkers Prev, 18: 1468-76.
[10] Ortega F, Silventoinen K, Tynelius P, Rasmussen F (2012). Muscular strength in male adolescents and premature death: cohort study of one million participants. BMJ, 345: e7279.
[11] LeongDP, TeoKK, RangarajanS, Lopez-JaramilloP, AvezumAJr, OrlandiniA, et al.; Prospective Urban Rural Epidemiology (PURE) Study investigators (2015). Prognostic value of grip strength: findings from the prospective urban rural epidemiology study. Lancet, 386: 266-73.
[12] Volaklis K, Halle M, Meisinger C (2015). Muscular strength as a strong predictor of mortality: a narrative review. Eur J Intern Med, 26: 303-10.
[13] Tanasescu M, Leitzmann M, Rimm E, Willet W, Stampfer M, Hu F (2002). Exercise type and intensity in relation to coronary heart disease in men. JAMA, 288: 1994-2000.
[14] Silventoinen K, Magnusson PK, Tynelius P, Batty GD, Rasmussen F (2009). Association of body size and muscle strength with incidence of coronary heart disease and cerebrovascular diseases: a population-based cohort study of one million Swedish men. Int J Epidemiol, 38: 110-18.
[15] Shrier I (2010). Muscle strength and body size and later cerebrovascular and coronary heart disease. Clin J Sports Med, 20: 131.
[16] Timpka S, Petersson I, Zhou C, Englund M (2014). Muscle strength in adolescent men and risk of cardiovascular disease events and mortality in middle age: a prospective cohort study. BMC Med, 12: 62.
[17] Åberg ND, Kuhn HG, Nyberg J, Waern M, Friberg P, Svensson J, et al. (2015). Influence of cardiovascular fitness and muscle strength in early adulthood on long-term risk of stroke in Swedish men. Stroke, 46: 1769-76.
[18] Maslow AL, Sui X, Colabianchi N, Hussey J, Blair SN (2010). Muscular strength and incident hypertension in normotensive and prehypertensive men. Med Sci Sports Exerc, 42: 288-95.
[19] Churilla JR, Magyari PM, Ford ES, Fitzhugh EC, Johnson TM (2012). Muscular strengthening activity patterns and metabolic health risk among US adults. J Diabetes, 4: 77-84.
[20] Jurca R, Lamonte MH, Barlow CE, Kampert JB, Church TS, Bair SN (2005). Association of muscular strength with incidence of metabolic syndrome in men. Med Sci Sports Exerc, 37: 1849-55.
[21] Grøntved A, Pan A, Mekary RA, Stampfer M, Willett WC, Manson JE, et al. (2014). Muscle-strengthening and conditioning activities and risk of type 2 diabetes: a prospective study in two cohorts of US Women. PLoS Med, 11: e1001587.
[22] Cheung CL, Nguyen US, Au E, Tan K, Kung A (2013). Association of handgrip strength with chronic diseases and multimorbidity: a cross-sectional study. Age, 35: 929-41.
[23] Volaklis KA, Halle M, Thorand B, Peters A, Ladwig KH, Schulz H, et al. (2016). Handgrip strength is inversely and independently associated with multimorbidity among older women: Results from the KORA-Age study. Eur J Intern Med, 31:35-40.
[24] Boyle PA, Buchman AS, Wilson RS, Leurgans SE, Bennett DA (2009). Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch Neurol, 66: 1339-44.
[25] Shin HY, Kim SW, Kim JM, Shin IS, Yoon JS (2012). Association of grip strength with dementia in a Korean older population. Int J Geriatr Psychiatry, 27: 500-5.
[26] Gustafsson H, Aasly J, Stråhle S, Nordström A, Nordström P (2015). Low muscle strength in late adolescence and Parkinson disease later in life. Neurology, 84: 1862-69.
[27] Buchman AS, Wilson RS, Boyle PA, Bienias JL, Bennett DA (2007). Grip strength and the risk of incident Alzheimer`s disease. Neuroepidemiology, 29: 66-73.
[28] Alfaro-Acha A, Al Snih S, Raji MA, Kuo YF, Markides KS, Ottenbacher KJ (2006). Handgrip strength and cognitive decline in older Mexican-Americans. J Gerontol A Biol Sci Med Sci, 61: 859-65.
[29] Fujita Y, Nakamura Y, Hiraoka J, Kobayashi K, Sakata K, Nagai M, et al. (1995). Physical-strength tests and mortality among visitors to health-promotion centers in Japan. J Clin Epidemiol, 48: 1349-59.
[30] Laukkanen P, Heikkinen E, Kauppinen M (1995). Muscle strength and mobility as predictors of survival in 74-84-year-old people. Age Aging, 24: 468-73.
[31] Rantanen T, Volpato S, Ferrucci L, Heikkinen E, Fried LP, Guralnik JM (2003). Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc, 51: 636-41.
[32] Rantanen T, Masaki K, He Q, Ross GW, Willcox BJ, White L (2012). Midlife muscle strength and human longevity up to age 100 years: a 44-year prospective study among a decedent cohort. Age, 34: 563-70.
[33] Gale RC, Martyn CN, Cooper C, Sayer AA (2007). Grip strength, body composition and mortality. Int J Epidemiol, 36: 228-35.
[34] Sasaki H, Kasagi F, Yamada M, Fujita S (2007). Grip strength predicts cause-specific mortality in middle-aged and elderly persons. Am J Med, 120: 337-42.
[35] Katzmarzyk PT, Craig CL (2002). Musculoskeletal fitness and risk of mortality. Med Sci Sports Exerc, 34: 740-44.
[36] Arvandi M, Strasser B, Meisinger C, Volaklis K, Gothe RM, Siebert U, et al. (2016). Gender differences in the association between grip strength and mortality in older adults: results from the KORA-age study. BMC Geriatr, 16:201.
[37] Ling CH, Taekema D, de Craen AJ, Gussekloo J, Westendorp RG, Maier AB (2010). Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study. Can Med Ass J, 182: 429-35.
[38] Cooper R, Kuh D, Hardy R; Mortality Review Group (2010). Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ, 341: c4467.
[39] Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, et al. (2006). The loss of skeletal muscle strength, mass, and quality in older adults: the Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci, 61: 1059-64.
[40] Lexell J (1995). Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci, 50: 11-6.
[41] Narici MV, Maganaris CN (2007). Plasticity of the muscle-tendon complex with disuse and aging. Exerc Sport Sci Rev, 35: 126-34.
[42] Proctor DN, Parker BA (2006). Vasodilation and vascular control in contracting muscle of the aging human. Microcirculation, 13: 315-27.
[43] Narici MV, Maganaris CN, Reeves ND, Capodaglio P (2003). Effect of aging on human muscle architecture. J Appl Physiol (1985), 95: 2229-34.
[44] Porter MM, Vandervoort AA, Lexell J (1995). Aging of human muscle: structure, function and adaptability. Scand J Med Sci Sports, 5: 129-42.
[45] Vandervoort AA (2002). Aging of the human neuromuscular system. Muscle Nerve, 25: 17-25.
[46] Stevens L, Firinga C, Gohlsch B, Bastide B, Mounier Y, Pette D (2000). Effects of unweighting and clenbuterol on myosin light and heavy chains in fast and slow muscles of rat. Am J Physiol Cell Physiol, 279: C1558-63.
[47] Syrový I, Hodný Z (1992). Non-enzymatic glycosylation of myosin: effects of diabetes and ageing. Gen Physiol Biophys, 11: 301-7.
[48] Ward NS (2006). Compensatory mechanisms in the aging motor system. Ageing Res Rev, 5: 239-54.
[49] Gordon T, Hegedus J, Tam SL (2004). Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease. Neurol Res, 26: 174-85.
[50] Manini T, Hong SL, Clark BC (2013). Aging and muscle: a neuron's perspective. Curr Opin Clin Nutr Metab Care, 16: 21-6.
[51] Doria E, Buonocore D, Focarelli A, Marzatico F (2012). Relationship between human aging muscle and oxidative system pathway. Oxid Med Cell Longev, 2012: 830257.
[52] Gheller BJF, Riddle ES, Lem MR, Thalacker-Mercer AE (2016). Understanding age-related changes in skeletal muscle metabolism: differences between females and males. Ann Rev Nutr, 36: 129-56.
[53] Drake JC, Wilson RJ, Yan Z (2016). Molecular mechanisms for mitochondrial adaptation to exercise training in skeletal muscle. FASEB J, 30: 13-22.
[54] Fiatarone MA, O'Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, et al. (1994). Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med, 330: 1769-75.
[55] Ferrando AA, Lane HW, Stuart CA, Davis-Street J, Wolfe RR (1996). Prolonged bed rest decreases skeletal muscle and whole body protein synthesis. Am J Physiol Endocrinol Metab, 270: E627-33.
[56] Hasten DL, Pak-Loduca J, Obert KA, Yarasheski KE (2000). Resistance exercise acutely increases MHC and mixed muscle protein synthesis rates in 78-84 and 23-32 yr olds. Am J Physiol Endocrinol Metab, 278: E620-26.
[57] Burtscher M (2013). Exercise limitations by the oxygen delivery and utilization systems in aging and disease: coordinated adaptation and deadaptation of the lung-heart muscle axis - a mini-review. Gerontology, 59: 289-96.
[58] Burtscher M, Förster H, Burtscher J (2008). Superior endurance performance in aging mountain runners. Gerontology, 54: 268-71.
[59] Faulkner JA, Davis CS, Mendias CL, Brooks SV (2008). The aging of elite male athletes: age-related changes in performance and skeletal muscle structure and function. Clin J Sport Med, 18: 501-7.
[60] Holm L, van Hall G, Rose AJ, Miller BF, Doessing S, Richter EA, et al. (2010). Contraction intensity and feeding affect collagen and myofibrillar protein synthesis rates differently in human skeletal muscle. Am J Physiol Endocrinol Metab, 298: E257-69.
[61] West DW, Burd NA, Coffey VG, Baker SK, Burke LM, Hawley JA, et al. (2011). Rapid aminoacidemia enhances myofibrillar protein synthesis and anabolic intramuscular signaling responses after resistance exercise. Am J Clin Nutr, 94: 795-803.
[62] Bautmans I, Van Puyvelde K, Mets T (2009). Sarcopenia and functional decline: pathophysiology, prevention and therapy. Acta Clin Belg, 64: 303-16.
[63] Snijders T, Verdijk LB, van Loon LJ (2009). The impact of sarcopenia and exercise training on skeletal muscle satellite cells. Ageing Res Rev, 8: 328-38.
[64] Hawke TJ, Garry DJ (2001). Myogenic satellite cells: physiology to molecular biology. J Appl Physiol, 91: 534-51.
[65] Leenders M, Verdijk LB, van der Hoeven L, van Kranenburg J, Nilwik R, van Loon LJ (2013). Elderly men and women benefit equally from prolonged resistance-type exercise training. J Gerontol A Biol Sci Med Sci, 68: 769-79.
[66] Porter C, Reidy PT, Bhattarai N, Sidossis LS, Rasmussen BB (2015). Resistance exercise training alters mitochondrial function in human skeletal muscle. Med Sci Sports Exerc, 47: 1922-31.
[67] Murias JM, Kowalchuk JM, Paterson DH (2010). Time course and mechanisms of adaptations in cardiorespiratory fitness with endurance training in older and young men. J Appl Physiol, 108: 621-27.
[68] Broskey NT, Greggio C, Boss A, Boutant M, Dwyer A, Schlueter L, et al. (2014). Skeletal muscle mitochondria in the elderly: effects of physical fitness and exercise training. J Clin Endocrinol Metab, 99: 1852-61.
[69] Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schimke JM, et al. (2003). Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes, 52: 1888-96.
[70] Landi F, Calvani R, Tosato M, Martone AM, Ortolani E, Savera G, et al. (2016). Protein intake and muscle health in old age: From Biological Plausibility to Clinical Evidence. Nutrients, 8: pii: E295.
[71] Draganidis D, Karagounis LG, Athanailidis I, Chatzinikolaou A, Jamurtas AZ, Fatouros IG (2016). Inflammaging and Skeletal Muscle: Can protein intake make a difference? J Nutr, 146: 1940-52.
[72] Baum JI, Kim IY, Wolfe RR (2016). Protein consumption and the elderly: What is the optimal level of intake? Nutrients, 8: pii: E359.
[73] HoustonDK, NicklasBJ, DingJ, HarrisTB, TylavskyFA, NewmanAB, et al.; Health ABC Study (2008). Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Clin Nutr, 87: 150-5.
[74] Bonjour JP (2011). Protein intake and bone health. Int J Vitam Nutr Res, 81: 134-42.
[75] Calvani R, Martone AM, Marzetti E, Onder G, Savera G, Lorenzi M, et al. (2014). Pre-hospital dietary intake correlates with muscle mass at the time of fracture in older hip-fractured patients. Front Aging Neurosci, 6: 269.
[76] Holwerda AM, Kouw IW, Trommelen J, Halson SL, Wodzig WK, Verdijk LB, et al. (2016). Physical activity performed in the evening increases the overnight muscle protein synthetic response to presleep Protein Ingestion in Older Men. J Nutr, 146: 1307-14.
[77] Tieland M, Dirks ML, van der Zwaluw N, Verdijk LB, van de Rest O, de Groot LC, et al. (2012). Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc, 13: 713-9.
[78] Yang Y, Breen L, Burd NA, Hector AJ, Churchward-Venne TA, Josse AR, et al. (2012). Resistance exercise enhances myofibrillar protein synthesis with graded intakes of whey protein in older men. Br J Nutr, 108: 1780-8.
[79] Marcell TJ (2003). Sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci, 58: M911-6.
[80] Moro T, Ebert SM, Adams CM, Rasmussen BB (2016). Amino acid sensing in skeletal muscle. Trends Endocrinol Metab, 27: 796-806.
[81] Cuthbertson D, Smith K, Babraj J, Leese G, Waddell T, Atherton P, et al. (2005). Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J, 19: 422-4.
[82] Kumar V, Selby A, Rankin D, Patel R, Atherton P, Hildebrandt W, et al. (2009). Age-related differences in the dose-response relationship of muscle protein synthesis to resistance exercise in young and old men. J Physiol, 587: 211-7.
[83] Boirie Y, Gachon P, Beaufrère B (1997). Splanchnic and whole-body leucine kinetics in young and elderly men. Am J Clin Nutr, 65: 489-95.
[84] Rasmussen BB, Fujita S, Wolfe RR, Mittendorfer B, Roy M, Rowe VL, et al. (2006). Insulin resistance of muscle protein metabolism in aging. FASEB J, 20: 768-9.
[85] Dickinson JM, Drummond MJ, Coben JR, Volpi E, Rasmussen BB (2013). Aging differentially affects human skeletal muscle amino acid transporter expression when essential amino acids are ingested after exercise. Clin Nutr, 32: 273-80.
[86] Guillet C, Prod'homme M, Balage M, Gachon P, Giraudet C, Morin L, et al. (2004). Impaired anabolic response of muscle protein synthesis is associated with S6K1 dysregulation in elderly humans. FASEB J, 18: 1586-7.
[87] Burd NA, Gorissen SH, van Loon LJ (2003). Anabolic resistance of muscle protein synthesis with aging. Exerc Sport Sci Rev, 41: 169-73.
[88] Pennings B, Koopman R, Beelen M, Senden JM, Saris WH, van Loon LJ (2011). Exercising before protein intake allows for greater use of dietary protein-derived amino acids for de novo muscle protein synthesis in both young and elderly men. Am J Clin Nutr, 93: 322-31.
[89] Anker SD, Coats AJ, Morley JE, Rosano G, Bernabei R, von Haehling S, et al. (2014). Muscle wasting disease: a proposal for a new disease classification. J Cachexia Sarcopenia Muscle, 5: 1-3.
[90] Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Westphal A, et al. (2014). Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr, 33: 929-36.
[91] Paddon-Jones D, Campbell WW, Jacques PF, Kritchevsky SB, Moore LL, Rodriguez NR, et al. (2015). Protein and healthy aging. Am J Clin Nutr, pii: ajcn084061. [Epub ahead of print].
[92] Rondanelli M, Klersy C, Terracol G, Talluri J, Maugeri R, Guido D, et al. (2016). Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderly. Am J Clin Nutr, 103: 830-40.
[93] Strasser B, Keinrad M, Haber P, Schobersberger W (2009). Efficacy of systematic endurance and resistance training on muscle strength and endurance performance in elderly adults--a randomized controlled trial. Wien Klin Wochenschr, 121: 757-64.
[94] Breen L, Phillips SM (2013). Interactions between exercise and nutrition to prevent muscle waste during ageing. Br J Clin Pharmacol, 75: 708-15.
[95] Burd NA, Andrews RJ, West DW, Little JP, Cochran AJ, Hector AJ, et al. (2012). Muscle time under tension during resistance exercise stimulates differential muscle protein sub-fractional synthetic responses in men. J Physiol, 590: 351-62.
[96] Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, et al. (2013). Acute skeletal muscle wasting in critical illness. JAMA, 310: 1591-600.
[97] Moisey LL, Mourtzakis M, Cotton BA, Premji T, Heyland DK, Wade CE, et al.; Nutrition and Rehabilitation Investigators Consortium (NUTRIC) (2013). Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patients. Crit Care 2013, 17: R206.
[98] Dirks ML, Wall BT, Snijders T, Ottenbros CL, Verdijk LB, van Loon LJ (2014). Neuromuscular electrical stimulation prevents muscle disuse atrophy during leg immobilization in humans. Acta Physiol, 210: 628-41.
[99] Strasser EM, Stättner S, Karner J, Klimpfinger M, Freynhofer M, Zaller V, et al. (2009). Neuromuscular electrical stimulation reduces skeletal muscle protein degradation and stimulates insulin-like growth factors in an age- and current-dependent manner: a randomized, controlled clinical trial in major abdominal surgical patients. Ann Surg, 249: 738-43.
[100] Thomas MN, Kufeldt J, Kisser U, Hornung HM, Hoffmann J, Andraschko M, et al. (2016). Effects of malnutrition on complication rates, length of hospital stay, and revenue in elective surgical patients in the G-DRG-system. Nutrition, 32: 249-54.
[101] Martone AM, Onder G, Vetrano DL, Ortolani E, Tosato M, Marzetti E, et al. (2013). Anorexia of aging: a modifiable risk factor for frailty. Nutrients, 5: 4126-33.
[102] Covinsky KE, Martin GE, Beyth RJ, Justice AC, Sehgal AR, Landefeld CS (1999). The relationship between clinical assessments of nutritional status and adverse outcomes in older hospitalized medical patients. J Am Geriatr Soc, 47: 532-8.
[103] Bos C, Benamouzig R, Bruhat A, Roux C, Valensi P, Ferrière F, et al. (2001). Nutritional status after short-term dietary supplementation in hospitalized malnourished geriatric patients. Clin Nutr, 20: 225-33.
[104] HeylandD, MuscedereJ, WischmeyerPE, CookD, JonesG, AlbertM, et al.; Canadian Critical Care Trials Group (2013). A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med, 368: 1489-97.
[105] van Zanten AR, Sztark F, Kaisers UX, Zielmann S, Felbinger TW, Sablotzki AR, et al. (2014). High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA, 312: 514-24.
[106] Bally MR, Blaser Yildirim PZ, Bounoure L, Gloy VL, Mueller B, Briel M, et al. (2016). Nutritional support and outcomes in malnourished medical inpatients: A systematic review and meta-analysis. JAMA Intern Med, 176: 43-53.
[107] Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, et al. (2012). Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr, 31: 652-8.
[108] DyerSM, CrottyM, FairhallN, MagazinerJ, BeaupreLA, CameronID, et al.; Fragility Fracture Network (FFN) Rehabilitation Research Special Interest Group (2016). A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr, 16: 158.
[109] Fiatarone Singh MA (2014). Exercise, nutrition and managing hip fracture in older persons. Curr Opin Clin Nutr Metab Care, 17: 12-24.
[110] Schürch MA, Rizzoli R, Slosman D, Vadas L, Vergnaud P, Bonjour JP (1998). Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med, 128: 801-9.
[111] Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, et al. (2013). Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc, 14: 542-59.
[112] Moore DR, Robinson MJ, Fry JL, Tang JE, Glover EI, Wilkinson SB, et al. (2009). Ingested protein dose response of muscle and albumin protein synthesis after resistance exercise in young men. Am J Clin Nutr, 89: 161-8.
[113] Churchward-Venne TA, Holwerda AM, Phillips SM, van Loon LJ (2016). What is the optimal amount of protein to support post-exercise skeletal muscle reconditioning in the older adult? Sports Med, 46: 1205-12.
[114] Drummond MJ (2015). A practical dietary strategy to maximize the anabolic response to protein in aging muscle. J Gerontol A Biol Sci Med Sci, 70: 55-6.
[115] Churchward-Venne TA, Breen L, Di Donato DM, Hector AJ, Mitchell CJ, Moore DR, Stellingwerff T, Breuille D, Offord EA, Baker SK, Phillips SM (2014). Leucine supplementation of a low-protein mixed macronutrient beverage enhances myofibrillar protein synthesis in young men: a double-blind, randomized trial. Am J Clin Nutr, 99: 276-86.
[116] Dickinson JM, Gundermann DM, Walker DK, Reidy PT, Borack MS, Drummond MJ, et al. (2014). Leucine-enriched amino acid ingestion after resistance exercise prolongs myofibrillar protein synthesis and amino acid transporter expression in older men. J Nutr, 144: 1694-702.
[117] Wall BT, Hamer HM, de Lange A, Kiskini A, Groen BB, Senden JM, et al. (2013). Leucine co-ingestion improves post-prandial muscle protein accretion in elderly men. Clin Nutr, 32: 412-9.
[118] Drummond MJ, Dreyer HC, Fry CS, Glynn EL, Rasmussen BB (2009). Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling. J Appl Physiol, 106: 1374-84.
[119] Tang JE, Moore DR, Kujbida GW, Tarnopolsky MA, Phillips SM (2009). Ingestion of whey hydrolysate, casein, or soy protein isolate: effects on mixed muscle protein synthesis at rest and following resistance exercise in young men. J Appl Physiol, 107: 987-92.
[120] Capuron L, Schroecksnadel S, Féart C, Aubert A, Higueret D, Barberger-Gateau P, et al. (2011). Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry, 70: 175-82.
[121] Strasser B, Becker K, Fuchs D, Gostner JM (2017). Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions. Neuropharmacology, 112(Pt B): 286-96.
[122] Strasser B, Berger K, Fuchs D (2014). Effects of a caloric restriction weight loss diet on tryptophan metabolism and inflammatory biomarkers in overweight adults. Eur J Nutr, 54: 101-7.
[123] Badawy AA (2017). Tryptophan availability for kynurenine pathway metabolism across the life span: Control mechanisms and focus on aging, exercise, diet and nutritional supplements. Neuropharmacology, 112(Pt B): 248-63.
[124] Strasser B, Fuchs D (2016). Diet versus exercise in weight loss and maintenance: Focus on tryptophan. Int J Tryptophan Res, 9: 9-16.
[125] Wurtman RJ, Wurtman JJ, Regan MM, McDermott JM, Tsay RH, Breu JJ (2003). Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios. Am J Clin Nutr, 77: 128-32.
[126] Strasser B, Fuchs D (2015). Role of physical activity and diet on mood, behavior, and cognition. Neurol Psychiatry Brain Res, 21: 118-126.
[127] Meeusen R (2014). Exercise, nutrition and the brain. Sports Med, 44, Suppl 1: S47-56.
[128] Agudelo LZ, Femenía T, Orhan F, Porsmyr-Palmertz M, Goiny M, Martinez-Redondo V, et al. (2014). Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell, 159: 33-45.
[129] Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A, et al. (2002). T cell apoptosis by tryptophan catabolism. Cell Death Differ, 9: 1069-77.
[130] Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, et al. (2002). Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science, 297: 1867-70.
[131] Frick B, Schroecksnadel K, Neurauter G, Leblhuber F, Fuchs D (2004). Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Clin Biochem, 37: 684-7.
[132] Pertovaara M, Raitala A, Lehtimäki T, Karhunen PJ, Oja SS, Jylhä M, et al. (2006). Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality. Mech Ageing Dev, 127: 497-9.
[133] Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature, 460: 392-5.
[134] Kaeberlein M (2010). Resveratrol and rapamycin: are they anti-aging drugs? Bioessays, 32: 96-9.
[135] Murr C, Grammer TB, Kleber ME, Meinitzer A, März W, Fuchs D (2015). Low serum tryptophan predicts higher mortality in cardiovascular disease. Eur J Clin Invest, 45: 247-54.
[136] Pedersen ER, Midttun Ø, Ueland PM, Schartum-Hansen H, Seifert R, Igland J, et al. (2011). Systemic markers of interferon-γ-mediated immune activation and long-term prognosis in patients with stable coronary artery disease. Arterioscler Thromb Vasc Biol, 31: 698-704.
[137] Schroecksnadel S, Sucher R, Kurz K, Fuchs D, Brandacher G (2011). Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells. Transpl Immunol, 25: 119-23.
[138] Wirleitner B, Schroecksnadel K, Winkler C, Schennach H, Fuchs D (2005). Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro. Immunol Lett, 100: 159-63.
[139] Strasser B, Geiger D, Schauer M, Gatterer H, Burtscher M, Fuchs D (2016). Effects of exhaustive aerobic exercise on tryptophan-kynurenine metabolism in trained athletes. PLoS One, 11: e0153617.
[140] WilliamsMA, HaskellWL, AdesPA, AmsterdamEA, BittnerV, FranklinBA, et al.; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Nutrition, Physical Activity, and Metabolism(2007). Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism. Circulation, 116: 572-84.
[141] NelsonME, RejeskiWJ, BlairSN, DuncanPW, JudgeJO, KingAC, et al.; American College of Sports Medicine; American Heart Association (2007). Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation, 116: 1094-105.
[142] GarberCE, BlissmerB, DeschenesMR, FranklinBA, LamonteMJ, LeeIM, et al.; American College of Sports Medicine (2011). American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc, 43: 1334-59.
[1] Tingting Sui,Di Liu,Tingjun Liu,Jichao Deng,Mao Chen,Yuanyuan Xu,Yuning Song,Hongsheng Ouyang,Liangxue Lai,Zhanjun Li. LMNA-mutated Rabbits: A Model of Premature Aging Syndrome with Muscular Dystrophy and Dilated Cardiomyopathy[J]. Aging and disease, 2019, 10(1): 102-115.
[2] Yuxiao Liao,Zhao Peng,Liangkai Chen,Yan Zhang,Qian Cheng,Andreas K. Nüssler,Wei Bao,Liegang Liu,Wei Yang. Prospective Views for Whey Protein and/or Resistance Training Against Age-related Sarcopenia[J]. Aging and disease, 2019, 10(1): 157-173.
[3] Dong Liu,Liqun Xu,Xiaoyan Zhang,Changhong Shi,Shubin Qiao,Zhiqiang Ma,Jiansong Yuan. Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury[J]. Aging and disease, 2019, 10(1): 116-133.
[4] Christin Weissleder,Guy Barry,Samantha J. Fung,Matthew W. Wong,Kay L. Double,Maree J. Webster,Cynthia Shannon Weickert. Reduction in IGF1 mRNA in the Human Subependymal Zone During Aging[J]. Aging and disease, 2019, 10(1): 197-204.
[5] Wanying Duan, Yuehua Pu, Haiyan Liu, Jing Jing, Yuesong Pan, Xinying Zou, Yilong Wang, Xingquan Zhao, Chunxue Wang, Yongjun Wang, Ka Sing Lawrence Wong, Ling Wei, Liping Liu, . Association between Leukoaraiosis and Symptomatic Intracranial Large Artery Stenoses and Occlusions: the Chinese Intracranial Atherosclerosis (CICAS) Study[J]. Aging and disease, 2018, 9(6): 1074-1083.
[6] Calvin Pak-Wing Cheng, Sheung-Tak Cheng, Cindy Woon-Chi Tam, Wai-Chi Chan, Winnie Chiu-Wing Chu, Linda Chiu-Wa Lam. Relationship between Cortical Thickness and Neuropsychological Performance in Normal Older Adults and Those with Mild Cognitive Impairment[J]. Aging and disease, 2018, 9(6): 1020-1030.
[7] Yu-Wen Huang, Ming-Fu Chiang, Che-Sheng Ho, Pi-Lien Hung, Mei-Hsin Hsu, Tsung-Han Lee, Lichieh Julie Chu, Hsuan Liu, Petrus Tang, Wailap Victor Ng, Dar-Shong Lin. A Transcriptome Study of Progeroid Neurocutaneous Syndrome Reveals POSTN As a New Element in Proline Metabolic Disorder[J]. Aging and disease, 2018, 9(6): 1043-1057.
[8] Manuel Scimeca, Federica Centofanti, Monica Celi, Elena Gasbarra, Giuseppe Novelli, Annalisa Botta, Umberto Tarantino. Vitamin D Receptor in Muscle Atrophy of Elderly Patients: A Key Element of Osteoporosis-Sarcopenia Connection[J]. Aging and disease, 2018, 9(6): 952-964.
[9] Charlene Greenwood, John Clement, Anthony Dicken, Paul Evans, Iain Lyburn, Richard M. Martin, Nick Stone, Peter Zioupos, Keith Rogers. Age-Related Changes in Femoral Head Trabecular Microarchitecture[J]. Aging and disease, 2018, 9(6): 976-987.
[10] Vinicius Alota Ignacio Pereira, Fabio Augusto Barbieri, Alessandro Moura Zagatto, Paulo Cezar Rocha dos Santos, Lucas Simieli, Ricardo Augusto Barbieri, Felipe Pivetta Carpes, Lilian Teresa Bucken Gobbi. Muscle Fatigue Does Not Change the Effects on Lower Limbs Strength Caused by Aging and Parkinson’s Disease[J]. Aging and disease, 2018, 9(6): 988-998.
[11] Ashok K. Shetty, Maheedhar Kodali, Raghavendra Upadhya, Leelavathi N. Madhu. Emerging Anti-Aging Strategies - Scientific Basis and Efficacy[J]. Aging and disease, 2018, 9(6): 1165-1184.
[12] Ze Teng, Aibo Wang, Peng Wang, Rui Wang, Wei Wang, Hongbin Han. The Effect of Aquaporin-4 Knockout on Interstitial Fluid Flow and the Structure of the Extracellular Space in the Deep Brain[J]. Aging and disease, 2018, 9(5): 808-816.
[13] Stefano Rizza, Marina Cardellini, Alessio Farcomeni, Pasquale Morabito, Daniele Romanello, Giovanni Di Cola, Maria Paola Canale, Massimo Federici. Low Molecular Weight Adiponectin Increases the Mortality Risk in Very Old Patients[J]. Aging and disease, 2018, 9(5): 946-951.
[14] Stefanie Hardt, Lucie Valek, Jinyang Zeng-Brouwers, Annett Wilken-Schmitz, Liliana Schaefer, Irmgard Tegeder. Progranulin Deficient Mice Develop Nephrogenic Diabetes Insipidus[J]. Aging and disease, 2018, 9(5): 817-830.
[15] Yong-Fei Zhao, Qiong Zhang, Jian-Feng Zhang, Zhi-Yin Lou, Hen-Bing Zu, Zi-Gao Wang, Wei-Cheng Zeng, Kai Yao, Bao-Guo Xiao. The Synergy of Aging and LPS Exposure in a Mouse Model of Parkinson’s Disease[J]. Aging and disease, 2018, 9(5): 785-797.
Full text



Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail:
Powered by Beijing Magtech Co. Ltd